Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...

According to Precedence Research, the global cell lysis and disruption market size is calculated at USD 6.22 billion in 2025 and is predicted to reach around USD 13.50 billion by 2034, representing a ...

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...

Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells. ScienceDaily . Retrieved February 11, 2025 from www.sciencedaily.com / releases / 2025 ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, blood vessels, and lymphatic tissue (mesenchymal cells). Despite being widely ...

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.

Pseudomonas aeruginosa triggers lung transplant rejection by killing regulatory T cells, revealing new targets for AMR ...